COMMUNIQUÉS West-GlobeNewswire
-
REPEAT – Cannabis Wheaton Income Corp. Announces Exclusive Data Licensing Agreement With Prominent Cannabis Testing, Analysis and Rating Company
19/12/2017 - 13:30 -
Onconova Therapeutics Announces License and Collaborative Development Agreement with HanX Biopharmaceuticals for ON 123300, a Dual Inhibitor of CDK4/6 + ARK5
19/12/2017 - 13:30 -
Myriad Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference
19/12/2017 - 13:05 -
Faron Pharmaceuticals Oy: Study update: Traumakine® Phase II/III INFORAAA trial for Multi-Organ Failure receives recommendation from IDMC
19/12/2017 - 13:01 -
PTS Diagnostics Announces New Portable Data Capture System for Screening Professionals
19/12/2017 - 13:00 -
REGENXBIO Announces IND Active for Phase I/II Trial of RGX-121 to Treat Mucopolysaccharidosis Type II
19/12/2017 - 13:00 -
Asterias Biotherapeutics Completes Enrollment of Entire SCiStar Study
19/12/2017 - 13:00 -
Axsome Therapeutics to Present at Biotech Showcase 2018
19/12/2017 - 13:00 -
Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with Vitiligo
19/12/2017 - 13:00 -
COPE Health Solutions expands COPE Health Scholars programs to Hawaii with Adventist Health Castle
19/12/2017 - 13:00 -
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
19/12/2017 - 12:30 -
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018
19/12/2017 - 12:00 -
Amphastar Announces Approval for Sodium Nitroprusside Injection, USP
19/12/2017 - 12:00 -
Transactions in relation to share buyback program
19/12/2017 - 11:23 -
HealthLynked Corp. Announces 12,926 Patient Member Profiles in Florida
19/12/2017 - 11:00 -
Saniona AB: Saniona Spin-Out, Scandion Oncology Raises DKK 2 Million and Prepares for a Potential Public Listing
19/12/2017 - 09:46 -
OSE Immunotherapeutics Presents New Data Analysis Supporting Continued Development of OSE-127 in Inflammatory Bowel Diseases
19/12/2017 - 08:00 -
BIOPHYTIS to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
19/12/2017 - 07:45 -
NICOX :Réalisations de 2017, lancement commercial de VYZULTA et aperçu des activités pour 2018
19/12/2017 - 07:31
Pages